What You Can Learn From Oxford Nanopore Technologies plc's (LON:ONT) P/SAfter Its 25% Share Price Crash
Apr 26
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedApr 26, 2024
DataAggregated Company Financials
Companies10
- 7D-1.1%
- 3M-27.6%
- 1Y-46.8%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.1%, driven by MaxCyte declining 5.8%. The industry has fallen 47% in the last year. Looking forward, earnings are forecast to grow by 11% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Apr 2024 | UK£1.5b | UK£317.6m | -UK£178,415,663.99 | 12.1x | -8.2x | 4.6x |
| Sun, 24 Mar 2024 | UK£1.8b | UK£296.0m | -UK£213,289,739.77 | 7353.2x | -8.6x | 6.2x |
| Tue, 20 Feb 2024 | UK£2.0b | UK£286.0m | -UK£189,379,093.03 | 6963.1x | -10.7x | 7.1x |
| Thu, 18 Jan 2024 | UK£2.9b | UK£450.3m | -UK£176,629,842.00 | 61.5x | -16.3x | 6.4x |
| Sat, 16 Dec 2023 | UK£3.1b | UK£450.1m | -UK£174,093,562.00 | 54.8x | -17.7x | 6.8x |
| Mon, 13 Nov 2023 | UK£3.0b | UK£456.4m | -UK£169,438,000.00 | 47.7x | -17.7x | 6.6x |
| Wed, 11 Oct 2023 | UK£2.9b | UK£458.4m | -UK£165,370,857.00 | 53.2x | -17.7x | 6.4x |
| Fri, 08 Sep 2023 | UK£3.1b | UK£440.4m | -UK£166,925,114.00 | 69.6x | -18.5x | 7x |
| Sun, 06 Aug 2023 | UK£3.4b | UK£476.5m | -UK£124,704,061.00 | 70.6x | -27.1x | 7.1x |
| Tue, 04 Jul 2023 | UK£2.9b | UK£476.6m | -UK£124,795,824.00 | 66.1x | -23.1x | 6.1x |
| Thu, 01 Jun 2023 | UK£3.4b | UK£477.3m | -UK£123,819,660.00 | 69.6x | -27.2x | 7x |
| Sat, 29 Apr 2023 | UK£3.1b | UK£463.9m | -UK£117,433,860.00 | 36.3x | -26.6x | 6.7x |
| Mon, 27 Mar 2023 | UK£2.8b | UK£459.3m | -UK£119,326,167.00 | 33.8x | -23.7x | 6.2x |
| Wed, 22 Feb 2023 | UK£3.2b | UK£443.5m | -UK£183,012,873.00 | 44.8x | -17.6x | 7.2x |
| Fri, 20 Jan 2023 | UK£3.5b | UK£442.8m | -UK£182,533,064.00 | 46.7x | -19x | 7.8x |
| Sun, 18 Dec 2022 | UK£3.3b | UK£443.4m | -UK£182,850,729.00 | 48.9x | -18x | 7.4x |
| Tue, 15 Nov 2022 | UK£3.8b | UK£448.1m | -UK£179,003,057.00 | 48.8x | -21.4x | 8.5x |
| Thu, 13 Oct 2022 | UK£213.4b | UK£449.7m | -UK£176,789,896.00 | 41.9x | -1206.8x | 474.4x |
| Sat, 10 Sep 2022 | UK£3.8b | UK£366.0m | -UK£191,147,579.00 | 47.3x | -19.9x | 10.4x |
| Mon, 08 Aug 2022 | UK£3.9b | UK£366.7m | -UK£188,118,954.00 | 49.7x | -21x | 10.8x |
| Wed, 06 Jul 2022 | UK£3.5b | UK£367.1m | -UK£188,274,901.00 | 41.2x | -18.5x | 9.5x |
| Fri, 03 Jun 2022 | UK£3.8b | UK£360.4m | -UK£192,210,622.00 | 42.7x | -19.9x | 10.6x |
| Sun, 01 May 2022 | UK£5.2b | UK£922.7m | -UK£165,738,471.00 | 45.1x | -31.3x | 5.6x |
| Tue, 29 Mar 2022 | UK£6.5b | UK£913.6m | -UK£309,287,647.00 | 47x | -21.2x | 7.2x |
| Thu, 24 Feb 2022 | UK£7.5b | UK£848.7m | -UK£185,446,952.00 | 30.9x | -40.6x | 8.9x |
| Sat, 22 Jan 2022 | UK£8.0b | UK£849.0m | -UK£184,521,973.00 | 30.4x | -43.4x | 9.4x |
| Mon, 20 Dec 2021 | UK£9.5b | UK£849.7m | -UK£187,885,597.00 | 30.9x | -50.4x | 11.1x |
| Wed, 17 Nov 2021 | UK£8.9b | UK£843.8m | -UK£189,687,308.00 | 23.4x | -47.1x | 10.6x |
| Fri, 15 Oct 2021 | UK£7.6b | UK£819.8m | -UK£189,275,706.00 | 28.5x | -40.3x | 9.3x |
| Sun, 12 Sep 2021 | UK£3.2b | UK£674.8m | -UK£136,626,800.35 | 29.5x | -23.3x | 4.7x |
| Tue, 10 Aug 2021 | UK£2.9b | UK£670.4m | -UK£160,499,800.35 | 63.3x | -18.2x | 4.4x |
| Mon, 03 May 2021 | UK£3.8b | UK£670.8m | -UK£88,500,847.08 | 80x | -42.8x | 5.6x |
Price to Earnings Ratio
-42.8x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 8.5x is higher than the industry's current PS ratio of 4.6x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 22% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 2.25% | |
| Healthcare | 7.50% | |
| Life Sciences | -1.06% | |
| Clinical Research and Equipment | -1.06% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ERGO Ergomed | UK£13.46 | 0.1% +UK£14.7m | 3.5% | PE46.7x | |
| HVO hVIVO | UK£0.29 | 7.1% +UK£12.9m | 77.9% | PE12.1x | |
| C4XD C4X Discovery Holdings | UK£0.12 | 45.9% +UK£9.5m | -16.4% | PE2.9x | |
| ONT Oxford Nanopore Technologies | UK£0.93 | 0.4% +UK£3.0m | -59.5% | PS4.7x | |
| PRM Proteome Sciences | UK£0.035 | 6.4% +UK£619.9k | -14.2% | PS2.1x |